← Leaderboards
Danny J Schust
University Of Missouri-Columbia
$11,685,332
Attributed
$16,813,271
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,813,271 · 7
By mechanism
R01$8,194,514 · 4
K12$7,775,803 · 1
R21$842,954 · 2
Top collaborators
- Toshihiko Ezashi13 shared
- Robert Michael Roberts8 shared
- Laura Clamon Schulz8 shared
- Alison J. Quayle4 shared
- Thomas E Spencer1 shared
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Toshihiko Ezashi$1,558,888
- Robert Michael Roberts$10,551,090
- Cheryl Susan Rosenfeld$4,164,723
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroMothersCellsEnsurePregnancyPlacentationEventFirst Pregnancy TrimesterCell ModelInvadedPre-EclampsiaPlacentaTrophoblastInduced Pluripotent Stem CellStem CellsBmp4SyncytiotrophoblastImmuneTissuesReproductivePhysiologicalEarly OnsetSiteConceptus
Grant awards (34)
Reproductive Scientist Development Program$901,849
K12 · FY2025 · HD · contact PI
Modeling Normal and Abnormal Trophoblasts$607,136
R01 · FY2025 · HD
Reproductive Scientist Development Program$812,177
K12 · FY2024 · HD · contact PI
Modeling Normal and Abnormal Trophoblasts$606,395
R01 · FY2024 · HD
Reproductive Scientist Development Program$172,598
K12 · FY2024 · HD · contact PI
Reproductive Scientist Development Program$917,603
K12 · FY2023 · HD · contact PI
Endometrial Basis for Infertility in Women with Recurrent Implantation Failure and Pregnancy Loss$653,560
R01 · FY2023 · HD
Modeling Normal and Abnormal Trophoblasts$634,720
R01 · FY2023 · HD
Reproductive Scientist Development Program (RSDP)$1,090,150
K12 · FY2022 · HD · contact PI
Modeling normal and abnormal trophoblasts$358,551
R01 · FY2022 · HD
Reproductive Scientist Development Program (RSDP) - NCI Supplement$137,000
K12 · FY2022 · HD · contact PI
Reproductive Scientist Development Program (RSDP)$1,118,776
K12 · FY2021 · HD · contact PI
Modeling normal and abnormal trophoblasts$358,551
R01 · FY2021 · HD
VTCN1 regulation of MHC in early human placental development$193,750
R21 · FY2021 · AI · contact PI
Reproductive Scientist Development Program (RSDP)$987,994
K12 · FY2020 · HD · contact PI
Modeling normal and abnormal trophoblasts$407,227
R01 · FY2020 · HD
VTCN1 regulation of MHC in early human placental development$232,500
R21 · FY2020 · AI · contact PI
Reproductive Scientist Development Program (RSDP)$137,000
K12 · FY2020 · HD · contact PI
Reproductive Scientist Development Program (RSDP)$987,994
K12 · FY2019 · HD · contact PI
Modeling normal and abnormal trophoblasts$450,099
R01 · FY2019 · HD
Reproductive Scientist Development Program (RSDP)$512,662
K12 · FY2018 · HD · contact PI
Modeling normal and abnormal trophoblasts$463,632
R01 · FY2018 · HD
Pluripotent Stem Cells: Modeling syncytiotrophoblast development and pathogenesis$318,513
R01 · FY2017 · HD
Prevention of HIV transmission/acquisition through informed contraceptive choice$391,789
R01 · FY2016 · AI
Pluripotent Stem Cells: Modeling syncytiotrophoblast development and pathogenesis$315,327
R01 · FY2016 · HD
Pluripotent Stem Cells: Modeling syncytiotrophoblast development and pathogenesis$100,000
R01 · FY2016 · HD
Prevention of HIV transmission/acquisition through informed contraceptive choice$600,010
R01 · FY2015 · AI
Pluripotent Stem Cells: Modeling syncytiotrophoblast development and pathogenesis$310,549
R01 · FY2015 · HD
Prevention of HIV transmission/acquisition through informed contraceptive choice$499,148
R01 · FY2014 · AI
Pluripotent Stem Cells: Modeling syncytiotrophoblast development and pathogenesis$309,594
R01 · FY2014 · HD
Prevention of HIV transmission/acquisition through informed contraceptive choice$491,200
R01 · FY2013 · AI
Pluripotent Stem Cells: Modeling syncytiotrophoblast development and pathogenesis$318,513
R01 · FY2013 · HD
C. trachomatis increases transmission of HIV: mechanisms in the endocervix$181,977
R21 · FY2011 · AI · contact PI
C. trachomatis increases transmission of HIV: mechanisms in the endocervix$234,727
R21 · FY2010 · AI · contact PI